Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control
- PMID: 1570811
- DOI: 10.1093/ajcn/55.5.997
Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control
Abstract
The mineral status in phenylketonuria (PKU) was measured by single-photon densitometry of the distal radius and plasma concentrations in 26 subjects. Bone mineral content increased normally with age in the younger children despite strict dietary restrictions. Subjects aged greater than 8 y, however, were frequently below the normal curve for bone mineral content. Blood phenylalanine concentrations were significantly higher in the older group of subjects and this correlated with decreased compliance with dietary prescriptions. PKU children had significantly decreased plasma concentrations of alkaline phosphatase, magnesium, and parathyroid hormone. Subnormal concentrations of plasma zinc and plasma and red blood cell (RBC) copper were common, but RBC zinc was normal. We conclude that compliance with dietary therapy for PKU is associated with normal bone mineral development in young children. Older patients with PKU who follow the diet less carefully are at risk for low bone mineral content.
Similar articles
-
Zinc and copper status of treated children with phenylketonuria.JPEN J Parenter Enteral Nutr. 1981 Sep-Oct;5(5):406-9. doi: 10.1177/0148607181005005406. JPEN J Parenter Enteral Nutr. 1981. PMID: 7198157
-
Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria.Ann Nutr Metab. 2017;70(2):111-121. doi: 10.1159/000465529. Epub 2017 Mar 24. Ann Nutr Metab. 2017. PMID: 28334709 Free PMC article.
-
Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.Mol Genet Metab. 2004 May;82(1):76-82. doi: 10.1016/j.ymgme.2004.01.017. Mol Genet Metab. 2004. PMID: 15110326
-
Micronutrient status in phenylketonuria.Mol Genet Metab. 2013;110 Suppl:S6-17. doi: 10.1016/j.ymgme.2013.09.009. Epub 2013 Sep 19. Mol Genet Metab. 2013. PMID: 24113686 Review.
-
Optimising growth in phenylketonuria: current state of the clinical evidence base.Clin Nutr. 2012 Feb;31(1):16-21. doi: 10.1016/j.clnu.2011.09.001. Epub 2011 Sep 29. Clin Nutr. 2012. PMID: 21959353 Review.
Cited by
-
Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.J Inherit Metab Dis. 2002 Sep;25(5):347-61. doi: 10.1023/a:1020191515173. J Inherit Metab Dis. 2002. PMID: 12408184
-
Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.Orphanet J Rare Dis. 2018 Jun 26;13(1):101. doi: 10.1186/s13023-018-0839-x. Orphanet J Rare Dis. 2018. PMID: 29941009 Free PMC article.
-
Advances in the nutritional and pharmacological management of phenylketonuria.Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):61-8. doi: 10.1097/MCO.0000000000000002. Curr Opin Clin Nutr Metab Care. 2014. PMID: 24136088 Free PMC article. Review.
-
Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.PLoS One. 2012;7(9):e45165. doi: 10.1371/journal.pone.0045165. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028819 Free PMC article.
-
Bone development in children and adolescents with PKU.J Inherit Metab Dis. 2012 May;35(3):425-30. doi: 10.1007/s10545-011-9412-7. Epub 2011 Nov 11. J Inherit Metab Dis. 2012. PMID: 22076426
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical